1
Return

Allogeneic Transplantation in the rare disease MDS/MPN with Neutrophilia: Age and Disease Burden Determine Outcome

delete2026-06-16
delete0
PRE
AI
A
Annemarie Mohring
K
Katja Sockel
C
Christian Thiede
J
Jan Schröder
D
Daniel Wolff
M
Marina Kadantsev
M
Marek Werth
M
M. Schneider
T
Tabea Globuschuetz
G
Georg‐Nikolaus Franke
S
Sebastian Klein
J
Joachim Göthert
C
Cort Hendrik Claassen
G
Gesine Bug
H
H. Christian Reinhardt
A
Anna Hecht-So
K
Katharina S. Götze
S
Sarah Flossdorf
W
Wolfgang Bethge
M
Martin Bornhäuser
DOI：10.1016/j.jtct.2026.06.027delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En 中文
• Largest allo-HCT cohort reported for MDS/MPN with Neutrophilia • 5-year posttransplant Overall Survival probability was 47% • Younger age and low disease burden predicted better outcome • Relapse and non-relapse mortality remain major challenges • EZH2 and TET2 mutations were linked to inferior outcomes

Journal

Transplantation and Cellular Therapy cover
Transplantation and Cellular Therapy
IF:
4.4
Papers:
2.1K
Citations:
4.4K

Organization

No organization information available
Cited Papers

Cited Papers

Citing Papers

Citing Papers